(3 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{NortheasternU-Boston}} | {{NortheasternU-Boston}} | ||
<html> | <html> | ||
+ | <div class="igem_2017_content_wrapper"> | ||
+ | <!-- START EDITING HERE --> | ||
+ | <div class="container neu-wrapper"> | ||
+ | <div class="row jumbo"> | ||
+ | </html>{{NortheasternU-Boston-Sidebar}}<html> | ||
− | <div class=" | + | <div class="col-sm-9 basic-page collaborations-page"> |
+ | <div class="header"> | ||
+ | <h1>Collaborators</h1> | ||
+ | </div> | ||
+ | <div class="collaborations-panel"> | ||
+ | <h3>NEGEM Meetup</h3> | ||
+ | <p>We shared our progress with Tufts, Boston University, WPI, Harvard, and MIT on June 21. We got feedback on running killing assays and also heard concerns that AMPs were not suitable for clinical distribution. This feedback helped us to refine our focus on the foundational advance of post-translational modifications. We also completed surveys for WPI on lead contamination and for BU Hardware on microfluidics in synthetic biology.</p> | ||
+ | <div class="row collab-section-header"> | ||
+ | <div class="col-sm-3"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/2/2a/T--INSA-UPS_France--Logo.png" /> | ||
+ | </div> | ||
+ | <div class="col-sm-9"> | ||
+ | <h3>INSA-UPS</h3> | ||
+ | </div> | ||
+ | </div> | ||
+ | <p>We talked over Skype and email to team INSA-UPS concerning their work with AMPs for combatting cholera. We gave them feedback about their project and possible collaborations between our group including the opportunity for us to try to produce one of their AMPs in our cell-free reaction. Unfortunately the timing for this collaboration didn't pan out. In addition we completed their survey about a hypothetical water treatment device. We gave troubleshooting advice but were unable to test each others’ parts.</p> | ||
+ | <div class="row collab-section-header"> | ||
+ | <div class="col-sm-3"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/5/5f/T--NortheasternU-Boston--BU.png" /> | ||
+ | </div> | ||
+ | <div class="col-sm-9"> | ||
+ | <h3>Boston U</h3> | ||
+ | </div> | ||
+ | </div> | ||
+ | <p>We also talked to the Boston University Wetlab team working on cell-free expression for RNA controlled switches. We compared cell free protocols and discussed challenges in using the expression system but did not have time to test each other’s parts.</p> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="row neu-igem-footer"> | ||
+ | <!-- SPONSOR LOGOS --> | ||
+ | <div class="col-xs-12"> | ||
− | <div class=" | + | <!-- don't call these classes "sponsor" since adblock will destroy it --> |
− | < | + | <div class="neusponsor-container"> |
+ | <div class="neusponsor-header"> | ||
+ | <span class="neusponsor-title">Our Generous Sponsors</span> | ||
+ | </div> | ||
+ | <hr/> | ||
+ | <ul class="neusponsor-list"> | ||
+ | <li class="neusponsor-item"> | ||
+ | <a href="http://compasstherapeutics.com" class="neusponsor-item-link" target="_blank" | ||
+ | title="Compass Therapeutics"> | ||
+ | <img class="neusponsor-img" src="https://static.igem.org/mediawiki/2017/3/33/T--NortheasternU-Boston--SponsorCompass.png" | ||
+ | alt="Compass Therapeutics"/> | ||
+ | </a> | ||
+ | </li> | ||
+ | <li class="neusponsor-item"> | ||
+ | <a href="https://www.idtdna.com/site" class="neusponsor-item-link" target="_blank" | ||
+ | title="IDT Integrated DNA Technologies"> | ||
+ | <img class="neusponsor-img" src="https://static.igem.org/mediawiki/2017/8/84/T--NortheasternU-Boston--SponsorIDT.png" | ||
+ | alt="IDT Integrated DNA Technologies"/> | ||
+ | </a> | ||
+ | </li> | ||
+ | <li class="neusponsor-item"> | ||
+ | <a href="https://www.neb.com" class="neusponsor-item-link" target="_blank" | ||
+ | title="NEB New England Biolabs"> | ||
+ | <img class="neusponsor-img" src="https://static.igem.org/mediawiki/2017/d/d7/T--NortheasternU-Boston--SponsorNEB.png" | ||
+ | alt="NEB New England Biolabs"/> | ||
+ | </a> | ||
+ | </li> | ||
+ | <li class="neusponsor-item"> | ||
+ | <a href="http://www.northeastern.edu/cos/" class="neusponsor-item-link" target="_blank" | ||
+ | title="Northeastern University College of Science"> | ||
+ | <img class="neusponsor-img" src="https://static.igem.org/mediawiki/2017/5/5e/T--NortheasternU-Boston--SponsorNEUCoS.png" | ||
+ | alt="Northeastern University College of Science"/> | ||
+ | </a> | ||
+ | </li> | ||
+ | <li class="neusponsor-item"> | ||
+ | <a href="http://www.bioe.neu.edu" class="neusponsor-item-link" target="_blank" | ||
+ | title="Northeastern Univeristy Department of Bioengineering"> | ||
+ | <img class="neusponsor-img" src="https://static.igem.org/mediawiki/2017/7/7d/T--NortheasternU-Boston--SponsorNEUBioE.png" | ||
+ | alt="Northeastern University Department of Bioengineering"/> | ||
+ | </a> | ||
+ | </li> | ||
+ | <li class="neusponsor-item"> | ||
+ | <a href="http://www.che.neu.edu" class="neusponsor-item-link" target="_blank" | ||
+ | title="Northeastern University Department of Chemical Engineering"> | ||
+ | <img class="neusponsor-img" src="https://static.igem.org/mediawiki/2017/3/3a/T--NortheasternU-Boston--SponsorNEUChemE.png" | ||
+ | alt="Northeastern University Department of Chemical Engineering"/> | ||
+ | </a> | ||
+ | </li> | ||
− | + | </ul> | |
− | + | </div> | |
− | </ | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
+ | </div> | ||
</div> | </div> | ||
− | + | </div> | |
− | + | </div> | |
− | <div | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | </div> | + | |
− | + | ||
− | + | ||
</html> | </html> |
Latest revision as of 00:56, 2 November 2017
Collaborators
NEGEM Meetup
We shared our progress with Tufts, Boston University, WPI, Harvard, and MIT on June 21. We got feedback on running killing assays and also heard concerns that AMPs were not suitable for clinical distribution. This feedback helped us to refine our focus on the foundational advance of post-translational modifications. We also completed surveys for WPI on lead contamination and for BU Hardware on microfluidics in synthetic biology.
INSA-UPS
We talked over Skype and email to team INSA-UPS concerning their work with AMPs for combatting cholera. We gave them feedback about their project and possible collaborations between our group including the opportunity for us to try to produce one of their AMPs in our cell-free reaction. Unfortunately the timing for this collaboration didn't pan out. In addition we completed their survey about a hypothetical water treatment device. We gave troubleshooting advice but were unable to test each others’ parts.
Boston U
We also talked to the Boston University Wetlab team working on cell-free expression for RNA controlled switches. We compared cell free protocols and discussed challenges in using the expression system but did not have time to test each other’s parts.